Cytokines and the central nervous system

Brain Research Bulletin

Volumn 54, Issue 4, 2001, Pages 329-338

  Szelényi, Judith ^a  

^a INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

Neurodegeneration; Neuroimunne interactions; Neuroprotection; Neurotransmitters; Th1 Th2 cytokine balance

Indexed keywords

CYTOKINE; CYTOKINE RECEPTOR; NEUROPEPTIDE; NEUROTRANSMITTER;

CELL DIFFERENTIATION; CELL INTERACTION; CELL SURVIVAL; CENTRAL NERVOUS SYSTEM; CYTOKINE PRODUCTION; GENE EXPRESSION; HUMAN; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; IMMUNOREGULATION; NERVE CELL; NERVE DEGENERATION; NEUROIMMUNOLOGY; NEUROPROTECTION; NEUROTOXICITY; NEUROTRANSMITTER RELEASE; NONHUMAN; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; TH1 CELL; TH2 CELL;

ANIMALS; BIOGENIC MONOAMINES; BRAIN; CELL DEATH; CELL SURVIVAL; CENTRAL NERVOUS SYSTEM; CYTOKINES; FEVER; HUMANS; INTERLEUKINS; RECEPTORS, CYTOKINE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0035278914     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0361-9230(01)00428-2     Document Type: Review

References (145)

1. Characterization of the beta-adrenergic receptor of the rat peritoneal macrophage
2. Interleukin-1 increases norepinephrine turnover in the spleen and lung in rats
3. Production of hemolymphopoietic cytokines (IL-6, IL-8, colony-stimulating factors) by normal human astrocytes in response to IL-1 beta and tumor necrosis factor-alpha
4. Relative contributions of peripheral and central sources to levels of IL-1 alpha in the cerebral cortex of mice; Assessment with species-specific enzyme immunoassays
5. Human interleukin (IL) 1 alpha, murine IL-1 alpha and murine IL-1 beta are transported from blood to brain in the mouse by a shared saturable mechanism
6. Tumor necrosis factor-alpha. A mediator of focal ischemic brain injury
7. Interleukin-6 and alpha-2-macroglobulin indicate an acute-phase state in Alzheimer's disease cortices
8. Alpha 2-, alpha 2A-, alpha 2B/2C-Adrenoceptor subtype antagonists prevent lipopolysaccharide-induced fever response in rabbits
9. Upregulation of RGS7 may contribute to tumor necrosis factor-induced changes in central nervous function
10. Immunoregulatory feedback between interleukin-1 and glucocorticoid hormones
11. Changes in blood hormone levels during the immune response
12. Immune-neuro-endocrine interactions; Facts and hypotheses
13. Cytokines as modulators of the hypothalamus-pituitary-adrenal axis
14. Immunoregulation mediated by the sympathetic nervous system
15. Modulation of inflammation and immunity by cyclic AMP
16. Interleukin-1 immunoreactive innervation of the human hypothalamus
17. Regional induction of tumor necrosis factor alpha expression in the mouse brain after systemic lipopolysaccharide administration
18. Distribution and characterization of tumor necrosis factor-alpha-like immunoreactivity in the murine central nervous system
19. Diurnal variations of tumor necrosis factor alpha mRNA and alpha-tubulin mRNA in rat brain
20. Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors
21. P2X receptors; An emerging channel family
22. Activation of cerebral cytokine gene expression and its correlation with onset of reactive astrocyte and acute-phase response gene expression in scrapie
23. Cerebral expression of multiple cytokine genes in mice with lymphocytic choriomeningitis
24. Transgenic models to study the actions of cytokines in the central nervous system
25. Increased plasma interleukin-1 activity in women after ovulation
26. Circulating interleukin-6 mediates the febrile response to localised inflammation in rats
27. Interleukin-1 and tumor necrosis factor-alpha synergistically mediate neurotoxicity; Involvement of nitric oxide and of N-methyl-D-aspartate receptors
28. Tumor necrosis factors protect neurons against metabolic-excitotoxic insults and promote maintenance of calcium homeostasis
29. Tumor necrosis factor-alpha production by astrocytes. Induction by lipopolysaccharide, IFN-gamma, and IL-1 beta
30. NGF mediates the neuroprotective effect of the beta2-adrenoceptor agonist clenbuterol in vitro and in vivo; Evidence from an NGF-antisense study
31. Glial cell-specific mechanisms of TGF-beta 1 induction by IL-1 in cerebral cortex
32. Macrophage inflammatory protein-1; A prostaglandin-independent endogenous pyrogen
33. Immunoregulation mediated by the sympathetic nervous system, II
34. Exercise and circadian rhythm-induced variations in plasma cortisol differentially regulate interleukin-1 beta (IL-1 beta), IL-6, and tumor necrosis factor-alpha (TNF alpha) production in humans; High sensitivity of TNF alpha and resistance of IL-6
35. Endotoxin-induced activation of cerebral catecholamine and serotonin metabolism; Comparison with interleukin-1
36. The role of interleukin-1 and tumor necrosis factor alpha in the neurochemical and neuroendocrine responses to endotoxin
37. The role of cytokines in infection-related behavior
38. Astrocytes are the primary source of tissue factor in the murine central nervous system. A role for astrocytes in cerebral hemostasis
39. The sympathetic nerve-an integrative interface between two 'supersystems'; The brain and the immune system
40. Modulation of lipopolysaccharide-induced tumor necrosis factor-alpha production by selective alpha- and beta-adrenergic drugs in mice
41. Presynaptic modulation of release of noradrenaline from the sympathetic nerve terminals in the rat spleen
42. Noradrenergic sympathetic neural interactions with the immune system; Structure and function
43. Purinergic modulation of interleukin-1 beta release from microglial cells stimulated with bacterial endotoxin
44. The role of cytokines in the neuropathology of stroke and neurotrauma
45. Mode of action of OB protein (leptin) on feeding
46. On the cellular source and function of interleukin 6 produced in the central nervous system in viral diseases
47. Ischemic and excitotoxic brain injury is enhanced in mice lacking the p55 tumor necrosis factor receptor
48. Interleukin 1 of the central nervous system is produced by ameboid microglia
49. Ceramide protects hippocampal neurons against excitotoxic and oxidative insults, and amyloid beta-peptide toxicity
50. Vasoactive hormones in endotoxin shock; A comparative study in cats and dogs
51. Action site of circulating interleukin-1 on the rabbit brain
52. Presynaptic receptors involved in the modulation of release of noradrenaline from the sympathetic nerve terminals of the rat thymus
53. An agonist of adenosine A3 receptors decreases interleukin-12 and interferon-gamma production and prevents lethality in endotoxemic mice
54. Regulation of cytokine and chemokine production by transmitters and co-transmitters of the autonomic nervous system
55. Stimulation of beta-adrenoceptors inhibits endotoxin-induced IL-12 production in normal and IL-10 deficient mice
56. The effect of norepinephrine on endotoxin-mediated macrophage activation
57. Interleukin-1beta system (ligand, receptor type I, receptor accessory protein and receptor antagonist), TNF-alpha, TGF-beta1 and neuropeptide Y mRNAs in specific brain regions during bacterial LPS-induced anorexia
58. Brain tumor development in rats is associated with changes in central nervous system cytokine and neuropeptide systems
59. A developmental study of cyclic AMP-response element binding protein (CREB) by in situ hybridization histochemistry and immunocytochemistry in the rat neocortex
60. Inhibition of IFN-gamma induction of class II MHC genes by cAMP and prostaglandins
61. Synergistic neurotoxic effects of combined treatments with cytokines in murine primary mixed neuron/glia cultures
62. Prevention of constitutive TNF receptor 1 signaling by silencer of death domains
63. Cyclic nucleotide phosphodiesterase type IV participates in the regulation of IL-10 and in the subsequent inhibition of TNF-alpha and IL-6 release by endotoxin-stimulated macrophages
64. Regulation of tumour necrosis factor production by mouse peritoneal macrophages; The role of cellular cyclic AMP
65. Cytokine and intracellular signaling regulation of tissue factor expression in astrocytes
66. Temporal and spatial relationships between lipopolysaccharide-induced expression of Fos, interleukin-1beta and inducible nitric oxide synthase in rat brain
67. Cytokines in sleep regulation
68. cAMP up-regulates IL-4 and IL-5 production from activated CD4+ T cells while decreasing IL-2 release and NF-AT induction
69. Effects of lipopolysaccharide and glucocorticoids on expression of interleukin-1 beta converting enzyme in the pituitary and brain of mice
70. Production of tumor necrosis factor and other cytokines by astrocytes stimulated with lipopolysaccharide or a neurotropic virus
71. Janus faces of NF-kappa B; Neurodestruction versus neuroprotection
72. Mechanisms of tumor necrosis factor alpha action on neurodegeneration; Interaction with insulin-like growth factor-1
73. Delayed mitochondrial dysfunction in excitotoxic neuron death; Cytochrome c release and a secondary increase in superoxide production
74. Febrile response to tissue inflammation involves both peripheral and brain IL-1 and TNF-alpha in the rat
75. Catecholamine influences and sympathetic neural modulation of immune responsiveness
76. Interferon-gamma plus lipopolysaccharide induction of delayed neuronal apoptosis in rat hippocampus
77. Pro-inflammatory and antiinflammatory cytokines in multiple sclerosis and central nervous system acquired immunodeficiency syndrome
78. Specificity of interleukin-1beta-induced changes in monoamine concentrations in hypothalamic nuclei; Blockade by interleukin-1 receptor antagonist
79. Neuronal activity increases the phosphorylation of the transcription factor cAMP response element-binding protein (CREB) in rat hippocampus and cortex
80. Evidence for different interactions between beta(1)- and beta(2)-adrenoceptor subtypes with adenylyl cyclase in the rat brain; A concentration-response study using forskolin
81. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins
82. Role of microglial-derived tumor necrosis factor in mediating CD14 transcription and nuclear factor kappa B activity in the brain during endotoxemia
83. Activation of SAPK/JNK by TNF receptor 1 through a noncytotoxic TRAF2-dependent pathway
84. Agents that increase cellular cAMP inhibit production of interleukin-2, but not its activity
85. Sympathetic nervous responses during cytokine-induced fever in conscious rabbits
86. Mechanism of interleukin 12-mediated toxicities during experimental viral infections; Role of tumor necrosis factor and glucocorticoids
87. Hippocampal norepinephrine-like voltammetric responses following infusion of corticotropin-releasing factor into the locus coeruleus
88. Cytokine production and its manipulation by vasoactive drugs
89. The cytokine response to strenuous exercise
90. Cytokines and anorexia; A brief overview
91. Regional cytokine, cytokine receptor and neuropeptide mRNA changes associated with behavioral and neuroanatomical abnormalities in persistent, noninflammatory virus infection of neonatal rats
92. Tumor necrosis factor and interleukin-1 beta; Suppression of food intake by direct action in the central nervous system
93. Up-regulation of monocytic IL-10 by tumor necrosis factor-alpha and cAMP elevating drugs
94. Detection of interleukin-1 bioactivity in various brain regions of normal healthy rats
95. Preconditioning-induced neuroprotection is mediated by reactive oxygen species
96. Release of tumor necrosis factor-alpha from macrophages. Enhancement and suppression are dose-dependently regulated by prostaglandin E2 and cyclic nucleotides
97. How the blood talks to the brain parenchyma and the paraventricular nucleus of the hypothalamus during systemic inflammatory and infectious stimuli
98. The role of interleukin 1 in acute neurodegeneration and stroke; Pathophysiological and therapeutic implications
99. CNS regulation of thermogenesis
100. Sixteenth Gaddum Memorial Lecture December 1996. Neuroimmune interactions; The role of cytokines
101. Annual review prize lecture cytokines-killers in the brain?
102. Differential regulation of brain and plasma TNFalpha produced after endotoxin shock
103. Ciliary neurotrophic factor protects hippocampal neurons from excitotoxic damage
104. Ciliary neurotrophic factor enhances the expression of NGF and p75 low-affinity NGF receptor in astrocytes
105. Neuroprotection mediated via neurotrophic factors and induction of neurotrophic factors
106. Regulation of tumor necrosis factor production by adrenaline and beta-adrenergic agonists
107. An interleukin-1 beta-induced noradrenaline release in the spleen is mediated by brain corticotropin-releasing factor; An in vivo microdialysis study in conscious rats
108. Activation of the interleukin-5 promoter by cAMP in murine EL-4 cells requires the GATA-3 and CLE0 elements
109. CREB and memory
110. Stimulation of alpha-adrenergic receptor augments the production of macrophage-derived tumor necrosis factor
111. ATP released by LPS increases nitric oxide production in raw 264.7 macrophage cell line via P2Z/P2X7 receptors
112. Neural-immune interactions in health and disease
113. Dialogue between the CNS and the immune system in lymphoid organs
114. The cytolytic P2Z receptor for extracellular ATP identified as a P2X receptor (P2X7)
115. The role of cerebral noradrenergic systems in the Fos response to interleukin-1
116. Isoproterenol regulates tumour necrosis factor, interleukin-10, interleukin-6 and nitric oxide production and protects against the development of vascular hyporeactivity in endotoxaemia
117. Contribution of differently localized alpha-2 and beta-adrenoceptors in the modulation of TNF-alpha and IL-10 production in endotoxaemic mice
118. Opposite role of alpha2- and beta-adrenoceptors in the modulation of interleukin-10 production in endotoxaemic mice
119. Differential involvement of sympathetic nervous system and immune system in the modulation of TNF-alpha production by alpha2- and beta-adrenoceptors in mice
120. Diurnal variations of interleukin-1 beta mRNA and beta-actin mRNA in rat brain
121. Cytokine-cytokine interactions and the brain
122. Endotoxin-induced appearance of immunoreactive interleukin-1 beta in ramified microglia in rat brain; A light and electron microscopic study
123. Noradrenaline inhibits lipopolysaccharide-induced tumor necrosis factor and interleukin 6 production in human whole blood
124. Prostaglandin-E2 is a potent inhibitor of human interleukin 12 production
125. A new concept in neurodegeneration; TNFalpha is a silencer of survival signals
126. A new mechanism of neurodegeneration; A pro-inflammatory cytokine inhibits receptor signaling by a survival peptide
127. Physiological role of cytoplasmic and non-synaptic release of neurotransmitter
128. Presynaptic modulation of choliergic andnoradrenergic neurotransmission; Interactions between them
129. Receptor-mediated local fine-tuning by noradrenergic innervation of neuroendocrine and immune systems
130. Role of high-affinity receptors and membrane transporters in nonsynaptic communication and drug action in the central nervous system
131. Neurochemistry and pharmacology of the major hippocampal transmitter systems; Synaptic and nonsynaptic interactions
132. Neurochemical, electrophysiological and immunocytochemical evidence for a noradrenergic link between the sympathetic nervous system and thymocytes
133. Local production of tumor necrosis factor alpha, interleukin 1, and interleukin 6 in meningococcal meningitis. Relation to the inflammatory response
134. Macrophage- and astrocyte-derived transforming growth factor beta as a mediator of central nervous system dysfunction in acquired immune deficiency syndrome
135. Is CREB a key to neuronal survival?
136. Cytokine-to-brain communication; A review & analysis of alternative mechanisms
137. The influence of intracellular levels of cyclic nucleotides on cell proliferation and the induction of antibody synthesis
138. Sympathetic activation triggers systemic interleukin-10 release in immunodepression induced by brain injury
139. IL-1 beta, IL-1 receptor type I and iNOS gene expression in rat brain vasculature and perivascular areas
140. Localization of interleukin-1 beta converting enzyme mRNA in rat brain vasculature; Evidence that the genes encoding the interleukin-1 system are constitutively expressed in brain blood vessels. Pathophysiological implications
141. Localization of stem cell factor mRNA in adult rat hippocampus
142. Expression of interleukin-1 receptor antagonist protein in post-mortem human brain tissues of Alzheimer's disease and control cases
143. Expression of interleukin-1 alpha, tumor necrosis factor alpha and interleukin-6 genes in astrocytes under ischemic injury
144. Synthesis of interleukin 6 (interferon-beta 2/B cell stimulatory factor 2) in human fibroblasts is triggered by an increase in intracellular cyclic AMP
145. The expression of transforming growth factor-beta1 (TGF-beta1) in hippocampal neurons; A temporary upregulated protein level after transient forebrain ischemia in the rat